MedPath

Autologous Serum Therapy versus Histaglobulin in management of Chronic Idiopathic Urticaria

Phase 4
Registration Number
CTRI/2024/02/063314
Lead Sponsor
AIIMS, Rishikesh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

18 years or above patient willing to give consent and not having any contraindication for the procedure

Exclusion Criteria

Active microbial infection,

Pregnancy or Lactation, Hypersensitivity to Histaglob injection, Immunosuppressed cases or uncontrolled Diabetes mellitus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath